Clinical Trial CTSUBRES1007-M


Phase III randomized trial of standard adjuvant endocrine therapy +/- chemo in patients with 1-3 positive nodes, hormone receptor positive and Her2 negative breast cancer with recurrence score (RS) of 25 or less

Principal Investigator(s)

John Murray


  • Protocol No. CTSUBRES1007-M
  • Open Date: 05/25/2011
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective:
  • Disease Sites: Breast
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Advantage Clinical Research; Meharry Medical College
  • Secondary Protocol No: S1007



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.